Novartis Sells Eye Drugs to Bausch for Up to $2.5B

The deal includes Xiidra, a prescription medicine for dry eye disease, that generated $487 million in sales last year.

Related Keywords

Switzerland ,Swiss , ,Japan Takeda Pharmaceutical Co ,Lomb Corp ,Novartis ,Chief Executive Officer Vas Narasimhan ,Takeda Pharmaceutical ,Basel Based Novartis ,Wall Street Journal ,